30 stocks will face lifting of restrictions next weekZhitong·Oct 31, 2025 at 08:16 AM301267-0.84%000409+3.29%
Huaxia Eye: Net profit attributable to the parent company in the first half of the year was 282 million yuan, a year-on-year increase of 6.20%Zhitong·Aug 24, 2025 at 02:39 AM301267-0.84%
Huaxia Eye: Has begun overseas expansion and will focus on considering acquisition targets primarily in Europe and AsiaZhitong·Apr 28, 2025 at 08:55 PM301267-0.84%
Huaxia Eye: Changes in tariffs will not adversely affect the company's normal operationsZhitong·Apr 22, 2025 at 07:57 AM301267-0.84%
Smart medical concept stocks surged in early trading, GMTECH hit the daily limitZhitong·Mar 18, 2025 at 08:42 PM002093+1.76%688580+4.02%
Huaxia Eye Hospital GroupLtd (SZSE:301267) May Have Issues Allocating Its CapitalSimplywall·Mar 5, 2025 at 07:51 PM301267-0.84%
Zeiss's new generation of all-femtosecond equipment has been approved for sale in ChinaUSHK News·Feb 28, 2025 at 01:51 AM301267-0.84%
These two ophthalmology companies started to incur losses less than 3 years after going publicWallstreetcn·Jan 20, 2025 at 12:51 AM301103+1.74%301239+1.24%
Huaxia Eye: The overall operation of the new refractive surgical technique is goodZhitong·Jan 14, 2025 at 08:58 PM301267-0.84%
Huaxia Eye has repurchased a total of 7.5278 million shares, costing 201 million yuanZhitong·Jan 8, 2025 at 04:18 AM301267-0.84%
Huaxia Eye has repurchased a total of 7.4525 million shares, costing 200 million yuanZhitong·Jan 3, 2025 at 02:24 AM301267-0.84%